Andelyn Biosciences is a cell and gene therapy contract development and manufacturing organization (CDMO) that provides viral vector and plasmid manufacturing, process development, and laboratory services.
Subscribe to see Andelyn Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Andelyn Biosciences is a biotechnology company headquartered in Columbus, United States. Xcout tracks 19 named people at Andelyn Biosciences, including Wade Macedone (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
13 more named people on record for Andelyn Biosciences, with roles, board committees and tenure — see the full roster →
A few of Andelyn Biosciences's closest competitors — see the full list of competitors and alternatives →
SGVector Holdings, LLC provides viral vector development and manufacturing services for cell and gene therapies. The company serves pharmaceutical companies, biotechnology firms, and academic institutions by offering scalable production platforms, vector design, process development, and analytical testing.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Vigene Biosciences, Inc. is a leader in viral vector-based gene delivery and manufacturing services. Headquartered in Rockville, Maryland, the company provides custom viral vector production and cGMP manufacturing capabilities for research and clinical applications.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Shanghai OBiO Technology (Group) Corp., Ltd. is a biotechnology contract development and manufacturing organization (CDMO/CRO) focused on gene and cell therapy services, including viral-vector development and manufacturing. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations developing gene-therapy and related biologics products.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Andelyn Biosciences? Suggest a correction · Work at Andelyn Biosciences? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.